title: Burden of Disease in Stage IV Non-Small Cell Lung Cancer: Comparing ALK Positive and ALK Negative Mutation Status in Egypt, Russia and the United Arab Emirates.
authors.affiliation: FIECON, London, UK.
authors.forename: M
authors.initials: M
authors.lastname: Fisher
authors.affiliation: Kantar Health, Munich, Germany.
authors.forename: J
authors.initials: J
authors.lastname: De Renteria
authors.affiliation: Kantar Health, Epsom, UK.
authors.forename: M
authors.initials: M
authors.lastname: Kuehl
authors.affiliation: Kantar Health, New York, NY, USA.
authors.forename: S
authors.initials: S
authors.lastname: Suponcic
authors.affiliation: FIECON, London, UK.
authors.forename: K
authors.initials: K
authors.lastname: Dharamshi